Priority Date: 20.12.05 (US 20050752146P)

Combination of an IAP-inhibitor and a taxane

  • Application ID: EP13156328
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Novartis Pharma AG is specialized in A61. Novartis Pharma AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 20.12.2005 - Priority Date (US 20050752146P)
  • 26.06.2013 - Publication A2 (EP2606933)
  • 15.10.2014 - Publication A3 (EP2606933)